 |
| BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence. |
|---|
|
   |
| BICX Gains National Media Love TRTC IVXX Broadens Reach |
|
 Hot Stock to Watch
|
Company: BioCorRx Inc. (OTCQB: BICX)
|
End of Day:
Price: 0.0851
Change (%): - 0.0099 (10.42)
Volume: 82,462 |
 |
BioCorRx, Inc. and Start Fresh Featured on MSNBC, SAMHSA and NIAAA Endorse Medication for Treatment of Alcohol Abuse Disorders
Los Angeles, April 28, 2015 (GLOBE NEWSWIRE) - BioCorRx, Inc. (BICX) announces MSNBC segment featuring Brady Granier, COO and interim CEO, alongside Start Fresh Program and Growing Pains alum, Jeremy Miller. The two were interviewed by Tamron Hall of NewsNation to discuss Jeremy’s success with the Start Fresh Program, a medication-assisted treatment program developed by BioCorRx that is used to treat alcohol and opioid addiction. The MSNBC segment originally aired on April 21, 2015 and can be viewed online here.
This television appearance followed a recent endorsement of medication-assisted treatment (MAT) for alcohol addiction by the Substance Abuse and Mental Health Services Administration (SAMHSA) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA). According to an article found here from Healio.com earlier this month, the groups collaborated on assembling a panel of experts to review data on the efficacy of treatment protocols that use medication in the treatment of alcoholism. The panel’s findings showed drugs such as Naltrexone, the FDA approved pharmaceutical used in the specially formulated implant that is part of the Start Fresh Program, to be effective in the treatment of alcohol abuse as well as managing relapse.
Continue Reading
|
 Yesterday's Top Performer
|
Company: Terra Tech Corp (OTCQB: TRTC)
|
End of Day:
Price: 0.1875
Change (%): + 0.0235 (14.33)
Volume: 2,106,429 |
 |
IVXX Premium Quality Cannabis Extracts are now Available at New Los Angeles Based Medical Cannabis Dispensary
Oakland, April 28, 2015 (GLOBE NEWSWIRE) - Terra Tech Corp (TRTC), is pleased to provide an update on the continued development of IVXX branded cannabis products. The Company is proud to announce that their brand of exceptional quality cannabis products is now available in Downtown Los Angeles, California at Grateful Meds. Grateful Meds is one of Downtown LA’s top medical cannabis facilities.
“We are thrilled that the IVXX brand is now available to patients in Downtown LA, and are excited to have added another patient-centric retailer,” explains Derek Peterson, CEO of Terra Tech. “We’ve heard great things as far as their commitment to the community as well as their patients. This relationship is consistent with our focus of aligning ourselves with quality and patient focused retailers.”
Continue Reading |
Other Small Cap News
|
Company: Novus Acquisition & Development Corp. (Pink Sheets: NDEV)
|
Weedmaps Editorial Highlights Novus MedPlan
MIAMI, FL--(Marketwired - Apr 28, 2015) - Novus Acquisition & Development Corp. (OTC PINK: NDEV), a provider of cost-savings healthcare programs through its wholly owned Novus Medical Group subsidiary, today announced that Weedmaps published an editorial discussing Novus MedPlan and its many benefits to medical marijuana patients, as well as a link for medical marijuana patients to enroll in Novus MedPlan.
A brief excerpt from the editorial reads, "We've used Novus' services firsthand and have already saved on products ranging from flower to edibles to hash. If you're sick of spending too much of your hard-earned money on your medicine and want more reasonable prices, join the Novus movement today."
Continue Reading
|
Company: Marley Coffee (OTCQB: JAMN)
|
|
Marley Coffee Expands Distribution in Chile
Premium Coffee Company Sees Continued Growth in Nationwide Food Service and Retail Accounts
DENVER--(BUSINESS WIRE)--Marley Coffee (OTCQB: JAMN), the sustainably grown, ethically farmed and artisan-roasted premium coffee company, today announced its expansion into two popular foodservice chains in Chile - Castaño, one of the country’s largest coffee chains, and Subway® sandwich stores as well as several grocery chains.
Beginning in summer 2015, the expected volume of Marley Coffee distributed to over 80 Castaño locations across the country is 132,000 pounds on an annual basis. Following an agreement signed in December 2014, Marley Coffee is also now officially available in 44 Subway locations in the region. By the end of 2015, it is expected that the brand will be served in 53 Subway stores nationwide with the potential to expand into other countries.
Continue Reading
|
Market News
|
By Scott Rutt: TheStreet
|
'Mad Money' Lightning Round: Buy, Buy, Buy Under Armour on Weakness
NEW YORK (TheStreet) -- Here's what Jim Cramer had to say about some of the stocks during the Mad Money Lightning Round Monday evening:
Agenus (AGEN): "I like it still. There's a lot more in the pipeline."
Windstream (WIN): "I think it's a steady income producer but I still prefer AT&T (T) or Verizon (VZ)."
Home Depot (HD): "It can still go down a few points. Then you can make your move."
Continue Reading
|
By Alex Rosenberg: CNBC
|
What record-high margin debt means for stocks
NYSE margin debt rose to an all-time high in March, according to recently released data from the stock exchange. But far from being a warning that stocks are getting frothy, some traders are using the news as a positive indicator.
At the end of March, NYSE margin debt sat at 476.4 billion dollars, up from 464.9 billion dollars at the end of February. And the wrinkle is that margin debt rose during March even as the S&P 500 dipped nearly 2 percent.
Margin debt is created when investors borrow money in order to buy stocks. If an investor buys $100 worth of stocks with $50 in capital, that individual has $50 of margin debt outstanding. Since margin debt provides leverage, it amplifies gains, but also increases the risk to an investor.
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
